June 17, 2025

FDA-Approved Sweetener Found in Vapes

New laboratory analysis found widespread use of neotame, a potent artificial sweetener, in most disposable e-cigarettes sold in the United States, including nicotine-free and nicotine-analogue products.

Conexiant

June 12, 2025

Smoking Cessation Drugs Show No Birth Risk

A large multinational cohort study found no increased risk of major congenital malformations associated with nicotine replacement therapy, varenicline, or bupropion use during early pregnancy.

Conexiant

June 09, 2025

New Fixed-Dose RSV Antibody Approved

The FDA has approved enflonsia, a fixed-dose monoclonal antibody, for preventing RSV lower respiratory tract disease in infants during their first season.

Conexiant

June 04, 2025

Big Tobacco's Medical Research Infiltrates Journals

Investigation reveals tobacco-funded studies appear in top medical journals despite industry bans, as companies invest billions in pharmaceutical subsidiaries.

Conexiant

June 02, 2025

New COVID Vaccine Approved for High-Risk Groups

After showing higher efficacy and a comparable safety profile to Spikevax, the FDA has approved Moderna’s mNEXSPIKE COVID-19 vaccine for high-risk patients.

Conexiant

November 01, 2024

Are Antibiotics Needed for Pediatric Pneumonia?

Nearly one in five children diagnosed with pneumonia in outpatient settings did not receive antibiotics, according to a recent study in JAMA Network Open.

Conexiant

April 29, 2024

Exposed to Agent Orange at US Bases, Veterans Face Cancer Without VA Compensation

A veteran's struggle for recognition of health issues linked to exposure to a controversial herbicide used by the military.

KFF Health News

October 30, 2024

First H5N1 Bird Flu Detected in U.S. Swine

H5N1 bird flu detected in a pig in Oregon - first case in U.S. swine; USDA assures no risk to pork supply despite spread to dairy herds & infection of 36 individuals.

Reuters

November 01, 2024

Study: U.S. Faces Higher Drug Shortages

A recent study compared drug shortage risks between the U.S. and Canada, revealing that the U.S. experienced approximately a 40% higher drug shortage risk compared to Canada, with trends persisting both pre-pandemic and during COVID-19. The study highlighted that Canada's approach was associated with a lower shortage risk.

Conexiant